Versant Vantage II GP, L.P. (CIK 1839790) reported 39 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2025-10-02). Recent activity: Sell LENZ (34,405 shares), Sell LENZ (49,701 shares), Sell LENZ (83,066 shares), Sell LENZ (57,502 shares), Sell LENZ (177 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-10-02 | LENZ Therapeutics, Inc. (LENZ) | Insider | Sell | 34,405 | $1.6M |
| 2025-10-02 | LENZ Therapeutics, Inc. (LENZ) | Insider | Sell | 49,701 | $2.3M |
| 2025-10-02 | LENZ Therapeutics, Inc. (LENZ) | Insider | Sell | 83,066 | $3.9M |
| 2025-10-02 | LENZ Therapeutics, Inc. (LENZ) | Insider | Sell | 57,502 | $2.7M |
| 2025-10-02 | LENZ Therapeutics, Inc. (LENZ) | Insider | Sell | 177 | $8,321 |
| 2025-10-02 | LENZ Therapeutics, Inc. (LENZ) | Insider | Sell | 123 | $5,782 |
| 2025-09-22 | LENZ Therapeutics, Inc. (LENZ) | Insider | Sell | 49,479 | $2.1M |
| 2025-09-22 | LENZ Therapeutics, Inc. (LENZ) | Insider | Sell | 24,370 | $1.0M |
| 2025-09-22 | LENZ Therapeutics, Inc. (LENZ) | Insider | Sell | 40,907 | $1.8M |
| 2025-09-22 | LENZ Therapeutics, Inc. (LENZ) | Insider | Sell | 20,148 | $866,364 |
| 2025-09-22 | LENZ Therapeutics, Inc. (LENZ) | Insider | Sell | 268 | $11,604 |
| 2025-09-22 | LENZ Therapeutics, Inc. (LENZ) | Insider | Sell | 132 | $5,716 |
| 2025-08-26 | LENZ Therapeutics, Inc. (LENZ) | Insider | Sell | 10,076 | $403,342 |
| 2025-08-26 | LENZ Therapeutics, Inc. (LENZ) | Insider | Sell | 5,668 | $230,064 |
| 2025-08-26 | LENZ Therapeutics, Inc. (LENZ) | Insider | Sell | 2,809 | $114,017 |
| 2025-08-26 | LENZ Therapeutics, Inc. (LENZ) | Insider | Sell | 50,270 | $2.0M |
| 2025-08-26 | LENZ Therapeutics, Inc. (LENZ) | Insider | Sell | 24,760 | $978,763 |
| 2025-08-26 | LENZ Therapeutics, Inc. (LENZ) | Insider | Sell | 2,149 | $85,788 |
| 2025-08-26 | LENZ Therapeutics, Inc. (LENZ) | Insider | Sell | 20,493 | $820,335 |
| 2025-08-26 | LENZ Therapeutics, Inc. (LENZ) | Insider | Sell | 43,978 | $1.7M |
| 2025-08-26 | LENZ Therapeutics, Inc. (LENZ) | Insider | Sell | 21,661 | $844,129 |
| 2025-08-26 | LENZ Therapeutics, Inc. (LENZ) | Insider | Sell | 3,465 | $136,868 |
| 2025-08-26 | LENZ Therapeutics, Inc. (LENZ) | Insider | Sell | 1,707 | $67,426 |
| 2025-08-26 | LENZ Therapeutics, Inc. (LENZ) | Insider | Sell | 1,058 | $42,235 |
| 2025-08-19 | LENZ Therapeutics, Inc. (LENZ) | Insider | Sell | 145,051 | $5.7M |
Source: SEC Form 4 filings · as of 2025-10-02